Meta-analysis of effect of beta-blocker therapy on mortality in patients with New York Heart Association class IV chronic congestive heart failure.
Whorlow
S L
SL
Clinical Pharmacology Unit, Department of Epidemiology & Preventive Medicine/Department of Medicine, Monash University/Alfred Hospital, Prahran, Victoria, Australia.
Krum
H
H
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D001578:Benzopyrans / Q000627:therapeutic use; D017298:Bisoprolol / Q000627:therapeutic use; D002227:Carbazoles / Q000627:therapeutic use; D000077261:Carvedilol; D004983:Ethanolamines / Q000627:therapeutic use; D006333:Heart Failure / Q000188:drug therapy* / Q000401:mortality*; D006801:Humans; D008790:Metoprolol / Q000627:therapeutic use; D000068577:Nebivolol; D011412:Propanolamines / Q000627:therapeutic use
D000319:Adrenergic beta-Antagonists; D001578:Benzopyrans; D002227:Carbazoles; D004983:Ethanolamines; D011412:Propanolamines; D000068577:Nebivolol; D000077261:Carvedilol; C024307:bucindolol; D008790:Metoprolol; D017298:Bisoprolol